Stempoint Capital’s Shattuck Labs STTK Stock Holding History

Stempoint Capital’s Portfolio STTK Stock Details STTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-147,752	Closed	-$1.05M	–	96
2023 Q4	$1.05M	Buy	+147,752	New	+$403K	0.28%	57

Other funds holding STTK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

TPC

Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return

CEI

Clark Estates Inc New York $416M AUM 6.04% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Stempoint Capital's STTK Position: Q1 2024 in Review

Stempoint Capital sold out of Shattuck Labs (STTK) in Q1 2024, closing a stake of 147,752 shares — an estimated $1.05M sold.

Stempoint Capital first reported a position in STTK in Q4 2023 and held it in 1 quarter. The position peaked at $1.05M in Q4 2023. 69 funds tracked by Wall St. Rank hold STTK as of Q1 2024.

Stempoint Capital reported no remaining Shattuck Labs position as of Q1 2024 after selling out during the quarter.
Stempoint Capital sold 147,752 Shattuck Labs shares in Q1 2024, an estimated $1.05M.
Stempoint Capital first reported a position in Shattuck Labs in Q4 2023 and held it in 1 quarter.
Stempoint Capital's Shattuck Labs position peaked at $1.05M in Q4 2023.
69 funds tracked by Wall St. Rank held Shattuck Labs as of Q1 2024.

Based on Stempoint Capital's 13F filing for Q1 2024, filed 14 May 2024.